InfiCure Bio has developed a new and unique pre-clinical mouse model, the N-IF mouse, which spontaneously develops fibrosis in multiple organs.
We offer expert led, tailored, high-quality drug validation services for R&D companies and CRO’s.
Our unique model offers extraordinary research advantages; is 100 percent reproducible, has a pathological progress similar to humans and displays a fibrosis preceded by inflammation.
Inficure Bio will break the status quo in anti-fibrotic drug development